Literature DB >> 8330406

Desirable standards for laboratory tests if they are to fulfill medical needs.

C G Fraser1, P H Petersen.   

Abstract

Many strategies to define desirable standards for laboratory tests to fulfill medical needs have been proposed over the last three decades. Traditional approaches are based on reference (normal) values, opinions of clinicians, the state of the art, views of experts, data on biological variation, and assessment of the effect of error on clinical use. All these approaches have advantages and disadvantages, but the consensus of experts reached over a decade ago that imprecision desirably be less than one-half of the within-subject biological variation still seems to provide the best set of generally applicable performance standards. Desirable bias is less than one-quarter of the group (within-subject plus between-subject) biological variation. Recent proposals are either restatements of traditional recommendations, further empirical suggestions, or models based on assessment of clinical needs, and have not been widely accepted. Both old and new studies on clinical opinions, sought by using structured questionnaires containing clinical vignettes designed to seek views on the magnitude of significant change, are flawed in design, execution, and data analysis. Until clinicians are more aware of test-result variability and clinical chemists gain quantitative knowledge on the interpretation of test results, it will be difficult to set desirable standards that fulfill actual medical needs, except in a few well-defined screening situations.

Mesh:

Year:  1993        PMID: 8330406

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Metabolomics in epidemiology: sources of variability in metabolite measurements and implications.

Authors:  Joshua N Sampson; Simina M Boca; Xiao Ou Shu; Rachael Z Stolzenberg-Solomon; Charles E Matthews; Ann W Hsing; Yu Ting Tan; Bu-Tian Ji; Wong-Ho Chow; Qiuyin Cai; Da Ke Liu; Gong Yang; Yong Bing Xiang; Wei Zheng; Rashmi Sinha; Amanda J Cross; Steven C Moore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-02-08       Impact factor: 4.254

2.  Analysis of In Vitro Cytotoxicity of Carbohydrate-Based Materials Used for Dissolvable Microneedle Arrays.

Authors:  Ezgi P Yalcintas; Daniel S Ackerman; Emrullah Korkmaz; Cheryl A Telmer; Jonathan W Jarvik; Phil G Campbell; Marcel P Bruchez; O Burak Ozdoganlar
Journal:  Pharm Res       Date:  2020-01-15       Impact factor: 4.200

3.  Self-monitoring of blood glucose: the use of the first or the second drop of blood.

Authors:  Johanna Hortensius; Robbert J Slingerland; Nanne Kleefstra; Susan J J Logtenberg; Klaas H Groenier; Sebastiaan T Houweling; Henk J G Bilo
Journal:  Diabetes Care       Date:  2011-02-02       Impact factor: 19.112

4.  Clinical Application of Overlapping Confidence Intervals for Monitoring Changes in Serial Clinical Chemistry Test Results.

Authors:  Jooyoung Cho; Dong Min Seo; Young Uh
Journal:  Ann Lab Med       Date:  2020-05       Impact factor: 3.464

5.  Quality of Liver and Kidney Function Tests among Public Medical Laboratories in Western Region of Amhara National Regional State of Ethiopia.

Authors:  Abaynesh Teka; Girma Kibatu
Journal:  Ethiop J Health Sci       Date:  2012-03

6.  Evaluation of method performance for oxidative stress biomarkers in urine and biological variations in urine of patients with type 2 diabetes mellitus and diabetic nephropathy.

Authors:  Ergul Belge Kurutas; Yakup Gumusalan; Ali Cetinkaya; Ekrem Dogan
Journal:  Biol Proced Online       Date:  2015-02-02       Impact factor: 3.244

7.  Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests.

Authors:  Najib Aziz; Roger Detels; Joshua J Quint; David Gjertson; Timothy Ryner; Anthony W Butch
Journal:  BMC Immunol       Date:  2019-09-14       Impact factor: 3.594

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.